← all papers · cardiovascular disease (15) Science journalism, not medical advice.
- TRT and Heart Risk: Is a Gel Safer Than a Shot?2026-07-05
Low testosterone tracks with worse blood vessel markers, and TRT improves most of them, but gel vs. injection safety claims are still unproven
Circulating Markers of Cardiovascular Health in Hypogonadism Before and After Testosterone Therapy: Molecular Aspects and Formulation Comparison hypogonadism testosterone therapy cardiovascular disease vascular health biomarkers narrative review
- 75% of Klinefelter Cases Go Undiagnosed2026-06-24
A review argues Klinefelter syndrome wrecks more than fertility, yet up to 75% of cases go undiagnosed
Klinefelter syndrome beyond hypogonadism: multisystem manifestations and a framework for clinical surveillance hypogonadism cardiovascular disease testosterone therapy narrative review
- Every Man After a Heart Attack Had ED2026-05-04
All 400 post-MI men had ED, and its severity was the single strongest predictor of quality of life after a heart attack.
Erectile Dysfunction and Quality of Life After Myocardial Infarction: A Cross-Sectional Study with Routine Point-of-Care Penile Doppler Ultrasonography erectile dysfunction cardiovascular disease cross-sectional quality of life vascular health
- Skipping Testosterone Therapy Raises Death Risk2026-04-22
In 408 men with pituitary tumors followed 8 years, TRT showed no increase in heart attack or stroke risk — but untreated low T was tied to higher mortality
Secondary Hypogonadism and Effects of Testosterone Replacement Therapy on Cardiovascular Events hypogonadism testosterone therapy cardiovascular disease cohort study
- Dyslipidemia and ED: Plausible but Not Proven2026-04-22
A review maps five pathways linking dyslipidemia to ED, then concedes direct evidence for all five is limited
Mechanisms of Dyslipidemia-Induced Erectile Dysfunction: A Narrative Review erectile dysfunction narrative review cardiovascular disease vascular health metabolic syndrome oxidative stress
- ED as an Early Warning Sign for Heart Damage2026-04-18
Review paper argues ED can show up 2-5 years before heart disease, or within months on certain cancer drugs
Erectile dysfunction as an early biomarker of cardiovascular toxicity: Mechanisms and clinical implications erectile dysfunction cardiovascular disease biomarkers narrative review
- 1 in 8 Diabetic Men Has ED, 660,000-Man Study Finds2026-04-17
659,501 men in Catalonia: ED prevalence was 12.6% in T2DM vs 8.3% in non-diabetic men — a 1.5-fold difference peaking at ages 55–64.
Prevalence and Clinical Characteristics of Erectile Dysfunction Among Men with Type 2 Diabetes in Primary Care: A Cross-Sectional Study in Catalonia diabetes erectile dysfunction cross-sectional epidemiology cardiovascular disease health services
- Newer Blood Pressure Drugs May Not Cause ED After All2026-04-09
A narrative review claims newer antihypertensives are ED-neutral or better, but cites no new data of its own
Erectile dysfunction and antihypertensive therapy: A critical reappraisal erectile dysfunction hypertension cardiovascular disease narrative review evidence quality
- ACE Inhibitors Beat Beta-Blockers for Female Sexual Function2026-03-17
ACEIs/ARBs improved all sexual function domains in hypertensive women; beta-blockers helped less, especially in uncontrolled hypertension (n=125, 3 months)
Sexual Function Among Hypertensive Females Receiving Beta-Blockers or ACEI/ARB and Thiazides: A Prospective Randomized Controlled Study sexual dysfunction cardiovascular disease women's health vascular health
- Three Metabolic Flags for Silent Heart Damage in ED Men2026-03-09
Dyslipidemia more than doubled the odds of diastolic heart dysfunction in 398 men with ED; BMI was the only factor linking to both types
Risk Factors Associated with Cardiac Dysfunction in Men with Erectile Dysfunction erectile dysfunction cardiovascular disease cross-sectional metabolic syndrome biomarkers
- Sexual Dysfunction as a Heart Disease Early Warning2026-02-22
ED may flag cardiovascular disease years before symptoms — the evidence for women lags far behind
Erectile and Clitoral Dysfunction as Harbingers of Cardiovascular Disease: A Perspective erectile dysfunction cardiovascular disease sexual dysfunction
- Half of Klinefelter Men Have Fatty Liver2026-02-20
Nearly half of Klinefelter patients had fatty liver, driven by metabolic syndrome — not low testosterone
Metabolic Dysfunction-associated Steatotic Liver Disease in Klinefelter Syndrome: High Prevalence Uncovers an Unmet Need hypogonadism genetics cardiovascular disease metabolic syndrome
- Cisplatin's Kidney Damage Cascades Into Heart Disease2026-02-13
41% of testicular cancer survivors had reduced kidney function a decade post-chemo; it cascades into hypertension, hyperlipidemia, and CVD
Renal Impairment and Late Toxicities Comparing Contemporary Chemotherapy Regimens for Testicular Cancer in a Real-World Setting testicular cancer survivorship cardiovascular disease vascular health
- Vitality Shields Diabetic Women from Sexual Dysfunction2026-01-08
Postmenopausal women with T2D had worse sexual function and quality of life — age raised FSD odds, but higher vitality reduced them.
Sexual Dysfunction and Quality of Life in Postmenopausal Type 2 Diabetes: Clinical and Laboratory Factors diabetes menopause sexual dysfunction quality of life cross-sectional women's health cardiovascular disease
- New Blood Marker Flags ED — At 71% Accuracy2026-01-05
sTWEAK, an inflammatory cytokine, rose with ED severity in 90 patients vs. 90 controls — AUC 0.776, 71% sensitivity and specificity
New biomarker for erectile dysfunction: Soluble tumor necrosis factor-like weak inducer of apoptosis erectile dysfunction biomarkers vascular health cardiovascular disease